Abstract
As a consequence of their increase in annual production and widespread distribution in the environment, nanoparticles potentially pose a significant public health risk. The sought-after catalytic activity granted by their physiochemical properties doubles as a hazard to physiological processes following exposure through inhalation, oral, transdermal, subcutaneous, and intravenous uptake. Upon uptake into the body, their size, morphology, surface charge, coating, and chemical composition augment the response of biological systems to the materials and enhance their toxicity. Identification of each property is necessary to predict the harm imposed by foreign nanomaterials in the body. Assay methods ranging from endotoxin and lactate dehydrogenase (LDH) signaling to apoptosis and oxidative stress detection supply valuable techniques for exposing biomarkers of nanoparticle-induced cellular damage. Spectroscopic investigation of epithelial barrier permeation and distribution within living cells reveals the proclivity of nanoparticles to penetrate the body’s natural defensive boundaries and deposit themselves in cytotoxic locations. Combination of the various characterization methodologies and assays is required for every new nanoparticulate system despite preexisting data for similar systems due to the lack of deterministic trends among investigated nanoparticles. The propensity of nanomaterials to denature proteins and oxidize substrates in their local environment generates significant concern for the applicability of several traditional in vitro assays, and the modification of susceptible approaches into novel methods suitable for the evaluation of nanoparticles comprises the focus of future work centered on nanoparticle toxicity analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Salata OV (2004) Applications of nanoparticles in biology and medicine. J Nanobiotechnol 2:3–3. https://doi.org/10.1186/1477-3155-2-3
Eifler AC, Thaxton CS (2011) Nanoparticle Therapeutics: FDA Approval, Clinical Trials, Regulatory Pathways, and Case Study. In: Hurst SJ (ed) Biomedical Nanotechnology: Methods and Protocols. Humana, Totowa, NJ, pp 325–338. https://doi.org/10.1007/978-1-61779-052-2_21
Priyadarsini S, Mukherjee S, Mishra M (2018) Nanoparticles used in dentistry: a review. J Oral Biol Craniofac Res 8(1):58–67. https://doi.org/10.1016/j.jobcr.2017.12.004
Copéret C, Héroguel F (2017) Recent advances in surface organometallic chemistry. In: Cornils B, Herrmann WA, Beller M, Paciello R (eds) Applied homogeneous catalysis with organometallic compounds. Wiley-VCH Verlag GmbH & Co, Weinheim, pp 1069–1084. https://doi.org/10.1002/9783527651733.ch15
Yan N, Xiao C, Kou Y (2010) Transition metal nanoparticle catalysis in green solvents. Coord Chem Rev 254(9):1179–1218. https://doi.org/10.1016/j.ccr.2010.02.015
Weiss J, Takhistov P, McClements DJ (2006) Functional materials in food nanotechnology. J Food Sci 71(9):R107–R116. https://doi.org/10.1111/j.1750-3841.2006.00195.x
Contado C (2015) Nanomaterials in consumer products: a challenging analytical problem. Front Chem 3:48. https://doi.org/10.3389/fchem.2015.00048
Raj S, Jose S, Sumod US, Sabitha M (2012) Nanotechnology in cosmetics: opportunities and challenges. J Pharm Bioallied Sci 4(3):186–193. https://doi.org/10.4103/0975-7406.99016
Boxberg F, Tulkki J (2004) Quantum dots: phenomenology, photonic and electronic properties, modeling and technology. the handbook of nanotechnology. Nanometer structures: theory, modeling, and simulation. SPIE Press, Bellingham. https://doi.org/10.1117/3.537698.ch4
Akbarzadeh A, Samiei M, Davaran S (2012) Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett 7(1):144–144. https://doi.org/10.1186/1556-276X-7-144
Smulders S, Luyts K, Brabants G, Landuyt KV, Kirschhock C, Smolders E, Golanski L, Vanoirbeek J, Hoet PHM (2014) Toxicity of nanoparticles embedded in paints compared with pristine nanoparticles in mice. Toxicol Sci 141(1):132–140. https://doi.org/10.1093/toxsci/kfu112
Rai M, Yadav A, Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27(1):76–83. https://doi.org/10.1016/j.biotechadv.2008.09.002
Sharifi S, Behzadi S, Laurent S, Forrest ML, Stroeve P, Mahmoudi M (2012) Toxicity of nanomaterials. Chem Soc Rev 41(6):2323–2343. https://doi.org/10.1039/c1cs15188f
Corbo C, Molinaro R, Parodi A, Furman NET, Salvatore F, Tasciotti E (2016) The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine 11(1):81–100. https://doi.org/10.2217/nnm.15.188
Kumar V, Sharma N, Maitra SS (2017) In vitro and in vivo toxicity assessment of nanoparticles. Int Nano Lett 7(4):243–256. https://doi.org/10.1007/s40089-017-0221-3
Clichici S, Filip A (2015) In vivo assessment of nanomaterials toxicity. Nanomaters toxicity and risk assessment. https://doi.org/10.5772/60707
Vasilakes AL, Dziubla TD, Wattamwar PP (2013) Polymeric nanoparticles. In: Bader RA (ed) Engineering polymer systems for improved drug delivery. John Wiley & Sons, Inc., pp 117–161. https://doi.org/10.1002/9781118747896.ch5
Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, Terada Y, Kano MR, Miyazono K, Uesaka M, Nishiyama N, Kataoka K (2011) Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol 6:815. https://doi.org/10.1038/nnano.2011.166 https://www.nature.com/articles/nnano.2011.166#supplementary-information
Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WCW (2009) Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett 9(5):1909–1915. https://doi.org/10.1021/nl900031y
Jiang W, Kim BYS, Rutka JT, Chan WCW (2008) Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3:145. https://doi.org/10.1038/nnano.2008.30 https://www.nature.com/articles/nnano.2008.30#supplementary-information
Jain RK, Stylianopoulos T (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7:653. https://doi.org/10.1038/nrclinonc.2010.139
Caldorera-Moore M, Guimard N, Shi L, Roy K (2010) Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin Drug Deliv 7(4):479–495. https://doi.org/10.1517/17425240903579971
Gratton SEA, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM (2008) The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci 105(33):11613–11618. https://doi.org/10.1073/pnas.0801763105
Huo S, Jiang Y, Gupta A, Jiang Z, Landis RF, Hou S, Liang XJ, Rotello VM (2016) Fully zwitterionic nanoparticle antimicrobial agents through tuning of core size and ligand structure. ACS Nano 10(9):8732–8737. https://doi.org/10.1021/acsnano.6b04207
Fleischer CC, Payne CK (2014) Nanoparticle–cell interactions: molecular structure of the protein corona and cellular outcomes. Acc Chem Res 47(8):2651–2659. https://doi.org/10.1021/ar500190q
Vroman L, Adams AL (1969) Identification of rapid changes at plasma–solid interfaces. J Biomed Mater Res 3(1):43–67. https://doi.org/10.1002/jbm.820030106
Owens DE, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307(1):93–102. https://doi.org/10.1016/j.ijpharm.2005.10.010
Li S-D, Huang L (2010) Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. J Control Release 145(3):178–181. https://doi.org/10.1016/j.jconrel.2010.03.016
Perry JL, Reuter KG, Kai MP, Herlihy KP, Jones SW, Luft JC, Napier M, Bear JE, DeSimone JM (2012) PEGylated PRINT nanoparticles: the impact of peg density on protein binding, macrophage association, biodistribution, and pharmacokinetics. Nano Lett 12(10):5304–5310. https://doi.org/10.1021/nl302638g
Cochran DB, Wattamwar PP, Wydra R, Hilt JZ, Anderson KW, Eitel RE, Dziubla TD (2013) Suppressing iron oxide nanoparticle toxicity by vascular targeted antioxidant polymer nanoparticles. Biomaterials 34(37):9615–9622. https://doi.org/10.1016/j.biomaterials.2013.08.025
Fan M, Zeng Y, Ruan H, Zhang Z, Gong T, Sun X (2017) Ternary nanoparticles with a sheddable shell efficiently deliver microRNA-34a against CD44-positive melanoma. Mol Pharm 14(9):3152–3163. https://doi.org/10.1021/acs.molpharmaceut.7b00377
Bahadar H, Maqbool F, Niaz K, Abdollahi M (2016) Toxicity of nanoparticles and an overview of current experimental models. Iran Biomed J 20(1):1–11. https://doi.org/10.7508/ibj.2016.01.001
Han SG, Newsome B, Hennig B (2013) Titanium dioxide nanoparticles increase inflammatory responses in vascular endothelial cells. Toxicology 306:1–8. https://doi.org/10.1016/j.tox.2013.01.014
Donaldson K, Stone V (2003) Current hypotheses on the mechanisms of toxicity of ultrafine particles. Ann Ist Super Sanita 39(3):405–410
Napierska D, Thomassen LC, Lison D, Martens JA, Hoet PH (2010) The nanosilica hazard: another variable entity. Part Fibre Toxicol 7(1):39. https://doi.org/10.1186/1743-8977-7-39
Bhattacharjee S (2016) DLS and zeta potential – what they are and what they are not? J Control Release 235:337–351. https://doi.org/10.1016/j.jconrel.2016.06.017
Lim J, Yeap SP, Che HX, Low SC (2013) Characterization of magnetic nanoparticle by dynamic light scattering. Nanoscale Res Lett 8(1):381–381. https://doi.org/10.1186/1556-276X-8-381
Pecora R (1968) Spectrum of light scattered from optically anisotropic macromolecules. J Chem Phys 49(3):1036–1043. https://doi.org/10.1063/1.1670189
Rodríguez-Fernández J, Pérez-Juste J, Liz-Marzán LM, Lang PR (2007) Dynamic light scattering of short Au rods with low aspect ratios. J Phys Chem C 111(13):5020–5025. https://doi.org/10.1021/jp067049x
Kaszuba M, Corbett J, Watson FM, Jones A (2010) High-concentration zeta potential measurements using light-scattering techniques. Philos Transact A Math Phys Eng Sci 368(1927):4439–4451. https://doi.org/10.1098/rsta.2010.0175
Brown MA, Goel A, Abbas Z (2016) Effect of electrolyte concentration on the stern layer thickness at a charged interface. Angew Chem Int Ed 55(11):3790–3794. https://doi.org/10.1002/anie.201512025
Pfeiffer C, Rehbock C, Hühn D, Carrillo-Carrion C, de Aberasturi DJ, Merk V, Barcikowski S, Parak WJ (2014) Interaction of colloidal nanoparticles with their local environment: the (ionic) nanoenvironment around nanoparticles is different from bulk and determines the physico-chemical properties of the nanoparticles. J R Soc Interface 11(96):20130931. https://doi.org/10.1098/rsif.2013.0931
Clogston JD, Patri AK (2011) Zeta potential measurement. In: McNeil SE (ed) Characterization of nanoparticles intended for drug delivery. Humana Press, Totowa, NJ, pp 63–70. https://doi.org/10.1007/978-1-60327-198-1_6
Lin P-C, Lin S, Wang PC, Sridhar R (2014) Techniques for physicochemical characterization of nanomaterials. Biotechnol Adv 32(4):711–726. https://doi.org/10.1016/j.biotechadv.2013.11.006
Muro S, Garnacho C, Champion JA, Leferovich J, Gajewski C, Schuchman EH, Mitragotri S, Muzykantov VR (2008) Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther 16(8):1450–1458. https://doi.org/10.1038/mt.2008.127
Lechtman E, Pignol JP (2017) Interplay between the gold nanoparticle sub-cellular localization, size, and the photon energy for radiosensitization. Sci Rep 7(1):13268. https://doi.org/10.1038/s41598-017-13736-y
Singh L, Parboosing R, Kruger HG, Maguire GEM, Govender T (2016) Intracellular localization of gold nanoparticles with targeted delivery in MT-4 lymphocytes. Adv Nat Sci Nanosci Nanotechnol 7(4). https://doi.org/10.1088/2043-6262/7/4/045013
Tammam SN, Azzazy HM, Breitinger HG, Lamprecht A (2015) Chitosan nanoparticles for nuclear targeting: the effect of nanoparticle size and nuclear localization sequence density. Mol Pharm 12(12):4277–4289. https://doi.org/10.1021/acs.molpharmaceut.5b00478
Hewitt RE, Vis B, Pele LC, Faria N, Powell JJ (2017) Imaging flow cytometry assays for quantifying pigment grade titanium dioxide particle internalization and interactions with immune cells in whole blood. Cytometry A 91(10):1009–1020. https://doi.org/10.1002/cyto.a.23245
Ostrowski A, Nordmeyer D, Boreham A, Holzhausen C, Mundhenk L, Graf C, Meinke MC, Vogt A, Hadam S, Lademann J, Ruhl E, Alexiev U, Gruber AD (2015) Overview about the localization of nanoparticles in tissue and cellular context by different imaging techniques. Beilstein J Nanotechnol 6:263–280. https://doi.org/10.3762/bjnano.6.25
Bao D, Oh ZG, Chen Z (2016) Characterization of silver nanoparticles internalized by Arabidopsis plants using single particle ICP-MS analysis. Front Plant Sci 7:32. https://doi.org/10.3389/fpls.2016.00032
Chen H-H, Chien C-C, Petibois C, Wang C-L, Chu YS, Lai S-F, Hua T-E, Chen Y-Y, Cai X, Kempson IM, Hwu Y, Margaritondo G (2011) Quantitative analysis of nanoparticle internalization in mammalian cells by high resolution X-ray microscopy. J Nanobiotechnol 9(1):14. https://doi.org/10.1186/1477-3155-9-14
Gottstein C, Wu G, Wong BJ, Zasadzinski JA (2013) Precise quantification of nanoparticle internalization. ACS Nano 7(6):4933–4945. https://doi.org/10.1021/nn400243d
Cohen O, Granek R (2014) Nucleus-targeted drug delivery: theoretical optimization of nanoparticles decoration for enhanced intracellular active transport. Nano Lett 14(5):2515–2521. https://doi.org/10.1021/nl500248q
McNamara AL, Kam WW, Scales N, McMahon SJ, Bennett JW, Byrne HL, Schuemann J, Paganetti H, Banati R, Kuncic Z (2016) Dose enhancement effects to the nucleus and mitochondria from gold nanoparticles in the cytosol. Phys Med Biol 61(16):5993–6010. https://doi.org/10.1088/0031-9155/61/16/5993
Hemmerich PH, von Mikecz AH (2013) Defining the subcellular interface of nanoparticles by live-cell imaging. PLoS One 8(4):e62018. https://doi.org/10.1371/journal.pone.0062018
Derk R, Davidson DC, Manke A, Stueckle TA, Rojanasakul Y, Wang L (2015) Potential in vitro model for testing the effect of exposure to nanoparticles on the lung alveolar epithelial barrier. Sens Biosensing Res 3:38–45. https://doi.org/10.1016/j.sbsr.2014.12.002
Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ (2015) TEER measurement techniques for in vitro barrier model systems. J Lab Autom 20(2):107–126. https://doi.org/10.1177/2211068214561025
Bannunah AM, Vllasaliu D, Lord J, Stolnik S (2014) Mechanisms of nanoparticle internalization and transport across an intestinal epithelial cell model: effect of size and surface charge. Mol Pharm 11(12):4363–4373. https://doi.org/10.1021/mp500439c
Ponsoda X, Jover R, Castell JV, Gómez-Lechón MJ (1991) Measurement of intracellular LDH activity in 96-well cultures: a rapid and automated assay for cytotoxicity studies. J Tissue Cult Methods 13(1):21–24. https://doi.org/10.1007/bf02388199
Brunner KT, Mauel J, Cerottini JC, Chapuis B (1968) Quantitative assay of the lytic action of immune lymphoid cells of (51)Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14(2):181–196
Babson AL, Babson SR (1973) Kinetic colorimetric measurement of serum lactate dehydrogenase activity. Clin Chem 19(7):766
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1):55–63. https://doi.org/10.1016/0022-1759(83)90303-4
Riss T, Moravec R, Niles A, Duellman S, Benink H, Worzella T, Minor L (2013, Updated 1 Jul 2016) Cell viability assays. [Internet]
Han X, Gelein R, Corson N, Wade-Mercer P, Jiang J, Biswas P, Finkelstein JN, Elder A, Oberdorster G (2011) Validation of an LDH assay for assessing nanoparticle toxicity. Toxicology 287(1–3):99–104. https://doi.org/10.1016/j.tox.2011.06.011
van Engeland M, Nieland LJW, Ramaekers FCS, Schutte B, Reutelingsperger CPM (1998) Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31(1):1–9. https://doi.org/10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R
Koopman G, Reutelingsperger C, Kuijten G, Keehnen R, Pals S, van Oers M (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84(5):1415–1420
Fan T-J, Han L-H, Cong R-S, Liang J (2005) Caspase family proteases and apoptosis. Acta Biochim Biophys Sin 37(11):719–727. https://doi.org/10.1111/j.1745-7270.2005.00108.x
Kaufmann SH, Lee SH, Meng XW, Loegering DA, Kottke TJ, Henzing AJ, Ruchaud S, Samejima K, Earnshaw WC (2008) Apoptosis-associated caspase activation assays. Methods 44(3):262–272. https://doi.org/10.1016/j.ymeth.2007.11.005
Keston AS, Brandt R (1965) The fluorometric analysis of ultramicro quantities of hydrogen peroxide. Anal Biochem 11(1):1–5. https://doi.org/10.1016/0003-2697(65)90034-5
Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130(4):1910–1917
Wang H, Joseph JA (1999) Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader11Mention of a trade name, proprietary product, or specific equipment does not constitute a guarantee by the United States Department of Agriculture and does not imply its approval to the exclusion of other products that may be suitable. Free Radic Biol Med 27(5):612–616. https://doi.org/10.1016/S0891-5849(99)00107-0
Gupta P, Jordan CT, Mitov MI, Butterfield DA, Hilt JZ, Dziubla TD (2016) Controlled curcumin release via conjugation into PBAE nanogels enhances mitochondrial protection against oxidative stress. Int J Pharm 511(2):1012–1021. https://doi.org/10.1016/j.ijpharm.2016.07.071
Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz A-G, Ahn B-W, Shaltiel S, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. In: Abelson JN (ed) Methods in enzymology, vol 186. Academic, Cambridge, MA, pp 464–478. https://doi.org/10.1016/0076-6879(90)86141-H
Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R (2003) Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329(1–2):23–38. https://doi.org/10.1016/s0009-8981(03)00003-2
Levine RL, Williams JA, Stadtman EP, Shacter E (1994) Carbonyl assays for determination of oxidatively modified proteins. In: Abelson JN (ed) Methods in enzymology, vol 233. Academic, Cambridge, MA, pp 346–357. https://doi.org/10.1016/S0076-6879(94)33040-9
Golbamaki N, Rasulev B, Cassano A, Marchese Robinson RL, Benfenati E, Leszczynski J, Cronin MT (2015) Genotoxicity of metal oxide nanomaterials: review of recent data and discussion of possible mechanisms. Nanoscale 7(6):2154–2198. https://doi.org/10.1039/c4nr06670g
Olive PL, Banath JP, Durand RE (2012) Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the “comet” assay. 1990. Radiat Res 178(2):AV35–AV42
OECD. Test no. 487: in vitro mammalian cell micronucleus test. OECD, Paris
Ellard S, Parry EM (1993) A modified protocol for the cytochalasin B in vitro micronucleus assay using whole human blood or separated lymphocyte cultures. Mutagenesis 8(4):317–320. https://doi.org/10.1093/mutage/8.4.317
OECD. Test no. 471: bacterial reverse mutation test. OECD, Paris
OECD. Test no. 473: in vitro mammalian chromosome aberration test. OECD, Paris
Doak SH, Manshian B, Jenkins GJ, Singh N (2012) In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines. Mutat Res 745(1–2):104–111. https://doi.org/10.1016/j.mrgentox.2011.09.013
Ayala A, Munoz MF, Arguelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Med Cell Longev 2014:360438. https://doi.org/10.1155/2014/360438
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351–358. https://doi.org/10.1016/0003-2697(79)90738-3
Moselhy HF, Reid RG, Yousef S, Boyle SP (2013) A specific, accurate, and sensitive measure of total plasma malondialdehyde by HPLC. J Lipid Res 54(3):852–858. https://doi.org/10.1194/jlr.D032698
Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11(1):81–128. https://doi.org/10.1016/0891-5849(91)90192-6
Weber D, Milkovic L, Bennett SJ, Griffiths HR, Zarkovic N, Grune T (2013) Measurement of HNE-protein adducts in human plasma and serum by ELISA-Comparison of two primary antibodies. Redox Biol 1:226–233. https://doi.org/10.1016/j.redox.2013.01.012
Gérard-Monnier D, Erdelmeier I, Régnard K, Moze-Henry N, Yadan J-C, Chaudière J (1998) Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chem Res Toxicol 11(10):1176–1183. https://doi.org/10.1021/tx9701790
Bartosh TJ, Ylostalo JH (2014) Macrophage inflammatory assay. Bio Protoc 4(14):e1180
Fujita T, Nolan GP, Ghosh S, Baltimore D (1992) Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev 6(5):775–787. https://doi.org/10.1101/gad.6.5.775
L-f C, Fischle W, Verdin E, Greene WC (2001) Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293(5535):1653–1657. https://doi.org/10.1126/science.1062374
Kinoshita S, Akira S, Kishimoto T (1992) A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc Natl Acad Sci 89(4):1473–1476
Smale ST (2010) Luciferase assay. Cold Spring Harb Protoc 2010(5):pdb prot5421. https://doi.org/10.1101/pdb.prot5421
Bang FB (1956) A bacterial disease of Limulus polyphemus. Bull Johns Hopkins Hosp 98(5):325–351
Hurley JC (1995) Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev 8(2):268–292
Smulders S, Kaiser JP, Zuin S, Van Landuyt KL, Golanski L, Vanoirbeek J, Wick P, Hoet PH (2012) Contamination of nanoparticles by endotoxin: evaluation of different test methods. Part Fibre Toxicol 9:41. https://doi.org/10.1186/1743-8977-9-41
Ding JL, Ho B (2010) Endotoxin detection – from limulus amebocyte lysate to recombinant factor C. In: Wang X, Quinn PJ (eds) Endotoxins: structure, function and recognition. Springer, Dordrecht, pp 187–208. https://doi.org/10.1007/978-90-481-9078-2_9
Alwis KU, Milton DK (2006) Recombinant factor C assay for measuring endotoxin in house dust: comparison with LAL, and (1 → 3)-β-D-glucans. Am J Ind Med 49(4):296–300. https://doi.org/10.1002/ajim.20264
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Savage, D.T., Hilt, J.Z., Dziubla, T.D. (2019). In Vitro Methods for Assessing Nanoparticle Toxicity. In: Zhang, Q. (eds) Nanotoxicity. Methods in Molecular Biology, vol 1894. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8916-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8916-4_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8915-7
Online ISBN: 978-1-4939-8916-4
eBook Packages: Springer Protocols